Clinical Trial Update: Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immune memory to Twinrix or comparator after a challenge dose 4 years post-vaccination, with results previously posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Twinrix (Hepatitis A and B vaccine, combined)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis A, Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2009-12-03